Jaguar Health, Inc. (JAGX) Form 424B3 — Jul 27, 2026
Jaguar Health, Inc. has filed a prospectus supplement for the resale of up to 5,483,086 shares of its common stock by selling stockholders. The shares were issued in connection with a Series P Preferred Stock financing completed on June 9, 2026, in which the company sold 240 shares of Series P Preferred Stock for an aggregate purchase price of $2 million.
Key figures
- Offering Price
- $0.9633
- Shares Offered
- 5,483,086
- Shares Outstanding
- 4,910,402
- Dilution Percentage
- >52.76%
- Equity Line Of Credit Amount
- $40 million
- Preferred Stock Financing Amount
- $2 million
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.